Reflect ScientificRSCF Pretax Margin % is 10.25% as of Sep. 2025. The stock has 4 warning signs investors should review. Among 817 Medical Devices & Instruments companies, Reflect Scientific ranks better than 54.83% on this metric.
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
Reflect Scientific Pretax Margin % Related Terms
Reflect Scientific Pretax Margin % Historical Data
* Premium members only.
The historical data trend for Reflect Scientific's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
RSCF vs GCTK, CBSC, NXGL: Pretax Margin % Comparison
For the Medical Instruments & Supplies subindustry, Reflect Scientific's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Reflect Scientific Pretax Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Reflect Scientific's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where Reflect Scientific's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Reflect Scientific (RSCF) has a Pretax Margin % of 10.25% as of Sep. 2025. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Reflect Scientific and its competitors. According to the industry distribution chart, Reflect Scientific ranks #369 out of 817 companies in the Medical Devices & Instruments industry, placing it in the top 45.2%.
Is Reflect Scientific's Pretax Margin % too high?
Reflect Scientific's current Pretax Margin % is 10.25%. The Medical Devices & Instruments industry median Pretax Margin % is 2.43. Reflect Scientific's value of 10.25% is 321.8% above this industry median. Based on the distribution chart, Reflect Scientific ranks #369 out of 817 companies in the Medical Devices & Instruments industry, which is above the industry midpoint.
How does Reflect Scientific's Pretax Margin % compare to GCTK and CBSC?
According to the Medical Devices & Instruments industry distribution chart, Reflect Scientific ranks #369 out of 817 companies for Pretax Margin %. This puts Reflect Scientific in the upper half of its industry. The industry median Pretax Margin % is 2.43. Reflect Scientific's value of 10.25% is 321.8% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Medical Devices & Instruments company?
The median Pretax Margin % among Medical Devices & Instruments companies is 2.43, based on 817 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Reflect Scientific's current Pretax Margin % of 10.25% is 321.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Reflect Scientific and its competitors. For the Medical Devices & Instruments industry, the median Pretax Margin % is 2.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Reflect Scientific's current Pretax Margin % is 10.25%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Reflect Scientific stock overvalued right now?
Reflect Scientific (RSCF) has a current Pretax Margin % of 10.25%. The current Pretax Margin % is 10.25% and 321.8% above the Medical Devices & Instruments industry median of 2.43. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Reflect Scientific (RSCF), the current Pretax Margin % is 10.25% as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Reflect Scientific Inc is engaged in the manufacture and distribution of products targeted at the life science market. The group's customers include hospitals, diagnostic laboratories, pharmaceutical and biotech companies, cold chain management, universities, government and private sector research facilities, and chemical and industrial companies. Its growing product portfolio includes ultra-low temperature freezers, blast freezers, solvent chillers, and refrigerated transportation in addition to supplying OEM products to the life sciences industry. The group's products are Cryometrix, GCFerrules, and Visacon. It recognizes revenue from the sale of scientific equipment for the life sciences and manufacturing industries.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
RSCF has been successfully added to your 